Breaking News
March 22, 2018 - Changes in the intestines may be responsible for reversal of diabetes after bariatric surgery
March 22, 2018 - iPads and Cancer; Clot Retrieval and Stroke: It’s PodMed Double T!
March 22, 2018 - Premature births linked to changes in mother’s bacteria
March 22, 2018 - Brain SPECT scans predict treatment outcomes in patients with depression
March 21, 2018 - Researchers succeed in integrating artificial organelles into cells of living organism
March 21, 2018 - Researchers discover ‘missing mutation’ in severe infant epilepsy
March 21, 2018 - Researchers develop statistics-based computational scheme to zoom in on brain function
March 21, 2018 - Verge joins Genomics England’s Discovery Forum industry partnership
March 21, 2018 - Trovagene Announces First Patient Successfully Completes Cycle 1 of Treatment with PCM-075 in Combination with Low Dose Cytarabine (LDAC) in AML Trial
March 21, 2018 - Congenital Cardiac Cath Tx Often Strays from Guidelines
March 21, 2018 - Marked increase in cardiovascular risk factors in women after preeclampsia
March 21, 2018 - New app may help predict, track manic and depressive episodes in bipolar patients
March 21, 2018 - Discovery of genes could lead to development of novel therapies for EBV-related cancers
March 21, 2018 - High-fat, high-cholesterol diet depletes ranks of artery-protecting immune cells
March 21, 2018 - Research misconduct allegations shadow likely CDC appointee
March 21, 2018 - Most Breast Ca Patients Fail to Get Genetic Counseling
March 21, 2018 - Lopsided ear function can lead to lopsided brain development
March 21, 2018 - Acupuncture helps manage menopausal symptoms, review finds
March 21, 2018 - Motor skill training may contribute to reading skills in obese children
March 21, 2018 - Poor dental health may be related to increased diabetes risk
March 21, 2018 - Chronic opioid users at increased risk of complications after spinal fusion surgery
March 21, 2018 - NSAID use linked to increased risk of atrial fibrillation
March 21, 2018 - Scientists develop brain “stethoscope” that can detect silent seizures
March 21, 2018 - New method predicts effects of global warming on disease
March 21, 2018 - Insurance Company Hurdles Burden Doctors, May Harm Patients
March 21, 2018 - Renal Transplant from HCV-Positive Donors Feasible
March 21, 2018 - Myelodysplastic syndrome: MedlinePlus Medical Encyclopedia
March 21, 2018 - Research reveals brain mechanism involved in language learning
March 21, 2018 - Many parents still hesitate to try early peanut introduction, survey finds
March 21, 2018 - Audiologist urges tinnitus sufferers facing ‘revolving door healthcare’ to seek support
March 21, 2018 - Study reveals impact of prostate cancer on wives and partners of sufferers
March 21, 2018 - ‘Almost a Miracle Drug’: What We Heard This Week
March 21, 2018 - Study shows NIH spent >$100 billion on basic science for new medicines
March 21, 2018 - Columbia researchers identify nerve cells that drive fruit fly’s escape behavior
March 21, 2018 - Sartorius Stedim Biotech selected by ABL Europe to supply single-use process technologies
March 21, 2018 - Increase in coffee consumption may help battle against colon cancer
March 21, 2018 - Hydrogel may accelerate healing of diabetic ulcers
March 21, 2018 - Dermira’s Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet Co-Primary Endpoints
March 21, 2018 - DePuy Synthes introduces ACTIS Total Hip System for improving initial implant stability
March 21, 2018 - ‘Oh, It Was Nothing’
March 21, 2018 - Herbal drug kratom linked to salmonella illnesses, CDC says
March 21, 2018 - New optical point-of-care device could enhance screening for thyroid nodules
March 21, 2018 - FDA Expands Approval of Adcetris (brentuximab vedotin) for First-Line Treatment of Stage III or IV Classical Hodgkin Lymphoma in Combination with Chemotherapy
March 21, 2018 - Eosinophilic Esophagitis: Late Manifestation of Allergic March
March 21, 2018 - Signaling pathway involving the Golgi apparatus identified in cells with Huntington’s disease
March 21, 2018 - Quintupling inhaled steroid doses may not benefit children with asthma
March 21, 2018 - Study shows clear connection between cardiovascular fitness in middle age and dementia risk
March 21, 2018 - Premature babies have higher risks of health complications in Bangladesh
March 21, 2018 - Child’s temperament and parenting influence weight gain in babies
March 21, 2018 - Researchers find the heart to be capable of arrhythmia termination after local gene therapy
March 21, 2018 - Inhealthcare to provide digital infrastructure for NHS to help protect people from falls
March 21, 2018 - Flu Season Finally Slowing Down
March 21, 2018 - Mixed Results for Shorter DAPT in ACS Patients
March 21, 2018 - Scientists discover fish scale-derived collagen effective for healing wounds
March 21, 2018 - Genomics England announces new partnership to improve efficiency of next-generation sequencing analysis
March 21, 2018 - Adjuvant AC chemotherapy found to be effective in treating HRD-positive breast cancer patients
March 21, 2018 - Researchers identify new treatment targets for lung diseases using big data
March 21, 2018 - Kids see more women in science than five decades ago
March 21, 2018 - Research shows link between chronic fatigue syndrome and lower thyroid hormone levels
March 21, 2018 - Alzheimer’s disease on the rise
March 21, 2018 - Two Agents Equal as Pretreatment for Adrenal Tumor Surgery
March 21, 2018 - ‘Icebreaker’ protein opens genome for T cell development, researchers find
March 21, 2018 - Women in medicine shout #Metoo about sexual harassment at work
March 21, 2018 - Mother’s pre-pregnancy waist size may be linked to child’s autism risk
March 21, 2018 - Second hand marijuana smoke can cause serious damage
March 21, 2018 - International study shows benefits of using MRI at the start of prostate cancer diagnosis
March 20, 2018 - Santhera Reports Outcome of Exploratory Trial with Idebenone in PPMS Conducted at the NIH
March 20, 2018 - ECG Patch Ups At-Home Afib Diagnosis in mSToPS Trial
March 20, 2018 - ROS-scavenging nanozymes for anti-inflammation therapeutics
March 20, 2018 - Genomics England announces appointment of global genomics pioneer as first CEO
March 20, 2018 - Test flight at German Aerospace Center in Cologne demonstrates functionality of deficopter
March 20, 2018 - Music therapy helps treat combat-related psychological injuries in military personnel
March 20, 2018 - Innovative psychotherapeutic treatment protocol for obsessive-compulsive disorders
March 20, 2018 - Weight loss after lap-band surgery alleviates arthritic knee pain
March 20, 2018 - New diabetes drug may help obese people shed body weight
March 20, 2018 - Novel Peanut OIT a Winner in Phase III Trial
March 20, 2018 - Can gene therapy be harnessed to fight the AIDS virus?
March 20, 2018 - Education and academic achievement can lessen effects of child abuse, neglect
March 20, 2018 - Researchers develop new algorithm to make CPR more effective
March 20, 2018 - Diabetes medication reduces chance of late miscarriage, premature birth among women with PCOS
Colon Ca: Elevated Preop CEA Not Indicative of Poor Prognosis

Colon Ca: Elevated Preop CEA Not Indicative of Poor Prognosis

image_pdfDownload PDFimage_print

Action Points

  • Note that this single-center observational study found that a normal post-operative CEA was as “protective” as a normal pre-operative CEA in patients with non-metastatic colon cancer.
  • This argues that routine preoperative CEA measurement may offer little information in terms of ultimate prognosis.

Elevated preoperative carcinoembryonic antigen (CEA) that normalizes after colon cancer surgery is not an indicator of poor prognosis, researchers reported.

Although current guidelines recommend measuring preoperative CEA in patients with colon cancer, the investigators said that considering the results of their study, they now question the utility of that approach and think it would be wiser to emphasize postoperative CEA instead.

The study, by Tsuyoshi Konishi, MD, PhD, of Memorial Sloan Kettering Cancer Center in New York City, and colleagues, was published in JAMA Oncology.

CEA is a colorectal cancer marker that the National Comprehensive Cancer Network, the American Society of Clinical Oncology, and the European Group on Tumour Markers all recommend be measured preoperatively in patients with nonmetastatic colon cancer.

For the study Konishi et al explained that the aim was to determine whether preoperative or postoperative CEA is more prognostic, and, more specifically, whether patients with elevated CEA that normalizes after resection have the same risk of recurrence as that of patients with normal preoperative CEA.

The retrospective cohort analysis included 1,027 patients (461 males, median age of 64) from a comprehensive cancer center who underwent curative resection for stages I to III colon adenocarcinoma between January 2007 and December 2014.

Preoperative CEA was normal in 715 patients (69.6%) and elevated in 312 (30.4%). Of the 312 with elevated preoperative CEA, 199 patients had postoperative CEA data available, and 142 of these had normalized postoperative CEA levels and 57 had elevated postoperative levels.

The patients were divided in three groups according to CEA status:

  • Patients with normal (≤5.0 ng/mL) preoperative CEA (normal preoperative group)
  • Patients with elevated (>5.0 ng/mL) preoperative CEA but normal postoperative CEA (normalized postoperative group)
  • Patients whose preoperative and postoperative CEA levels were both elevated (elevated postoperative group)

Patients with normal preoperative CEA had a 7.4% higher 3-year recurrence-free survival (RFS) than the combined cohorts with elevated preoperative CEA, but had RFS comparable to that of patients with normalized postoperative CEA. Patients with elevated postoperative CEA had “significantly” lower 3-year RFS (14.9%) than the combined cohorts with normal postoperative CEA.

The hazard function for each group indicated that the risk of recurrence was higher and peaked earlier in patients in the elevated postoperative CEA group.

A univariate analysis showed that older age, the presence of lymphovascular invasion, higher tumor-nodes-metastasis (TNM) staging, and elevated postoperative CEA were all associated with shorter RFS.

Multivariate analyses showed that elevated postoperative CEA (HR, 2.0; 95% CI 1.1 to 3.5), was independently associated with shorter RFS as well as with higher TNM stage, older age, and presence of lymphovascular invasion, while normalized postoperative CEA (HR, 0.77; 95% CI 0.45 to 1.30) was not.

“These findings suggest that with regard to prognosis, measuring postoperative rather than preoperative CEA is more instructive,” the researchers concluded.

Elevated postoperative CEA often normalizes after surgery and these patients have outcomes similar to those of patients with normal preoperative CEA. As a result, the team wrote, emphasis should be placed on postoperative CEA. Furthermore, since patients with elevated postoperative CEA tend to experience recurrence early, risk-adjusted and individualized surveillance strategies should be considered.

Writing in an accompanying commentary, Rebecca Anne Miksad, MD, MPH, director of Gastrointestinal Oncology at Beth Israel Deaconess Medical Center in Boston, and Neal J. Meropol, MD, division chief of Hematology and Oncology at University Hospitals Cleveland Medical Center Case Comprehensive Cancer Center, said: “This study highlights the potential of real-world evidence to contribute insights that might ultimately lead to changes in clinical guidelines and standards of care.”

Miksad and Meropol noted that the weaknesses of the study — such as generalizability, potential selection biases, and inconsistency and attrition in follow-up — were typical for an observational study that included cohorts of patients from a single institution, but the results lay important groundwork for additional research. Furthermore, the editorial states, getting corroborative evidence from other real-world settings could justify changes in clinical practice recommendations without the need to go through a prospective randomized trial.

The research was funded in part by the National Institutes of Health/National Cancer Institute.

Konishi and co-authors reported having no conflicts of interest.

Miksad and Meropol reported being employees of Flatiron Health in New York City.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner


Tagged with:

About author

Related Articles